QID 751141

Date Published: 2021-09-20

QID 751141: SUSE Enterprise Linux Security Update for postgresql12 (SUSE-SU-2021:3119-1)

This update for postgresql12 fixes the following issues: - cve-2021-3677: fixed memory disclosure in certain queries (bsc#1189748).
- fixed build with llvm12 on s390x (bsc#1185952).
- re-enabled icu for postgresql 10 (bsc#1179945).
- made the dependency of postgresqlxx-server-devel on llvm and clang optional (bsc#1187751).
- llvm12 breaks postgresql 11 and 12 on s390x.
Use llvm11 as a workaround (bsc#1185952).

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation allows attacker to compromise the system.

  • CVSS V3 rated as Medium - 4.2 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Upgrade to the latest package which contains the patch. To install this SUSE Security, Update use YaST online_update. Alternatively you can run the command listed for your product. To install packages using the command line interface, use command "yum update". Refer to Suse security advisory: SUSE-SU-2021:3119-1 to address this issue and obtain further details.
    Vendor References

    CVEs related to QID 751141

    CVE-2021-3677 |
    Software Advisories
    Advisory ID Software Component Link
    SUSE-SU-2021:3119-1 SUSE Enterprise Linux URL Logo lists.suse.com/pipermail/sle-security-updates/2021-September/009453.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].